SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-117673
Filing Date
2016-05-04
Accepted
2016-05-04 15:56:06
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6679_110q.htm 10-Q 700852
2 EX-10.1 a16-6679_1ex10d1.htm EX-10.1 32920
3 EX-31.1 a16-6679_1ex31d1.htm EX-31.1 12245
4 EX-31.2 a16-6679_1ex31d2.htm EX-31.2 12397
5 EX-32 a16-6679_1ex32.htm EX-32 7534
  Complete submission text file 0001104659-16-117673.txt   4295207

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imgn-20160331.xml EX-101.INS 843303
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgn-20160331.xsd EX-101.SCH 46304
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imgn-20160331_cal.xml EX-101.CAL 41347
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imgn-20160331_def.xml EX-101.DEF 179915
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT imgn-20160331_lab.xml EX-101.LAB 356005
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgn-20160331_pre.xml EX-101.PRE 306358
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 161619194
SIC: 2834 Pharmaceutical Preparations